- Status:
- In progress
- Technology type:
- Medicine
- Decision:
- Selected
- Reason for decision:
- Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
- Process:
- STA Standard
- ID number:
- 6593
Provisional Schedule
- Committee meeting: 1:
- 23 July 2026
- Expected publication:
- 17 September 2026
Project Team
- Project lead
- Thomas Feist
Email enquiries
If you have any queries please email TAteam3@nice.org.uk
Stakeholders
- Companies sponsors
- Arrowhead Pharmaceuticals
- Others
- Department of Health and Social Care
- Health Technology Wales
- NHS England
- University Hospital Birmingham Foundation Trust, Department of Endocrinology
- Patient carer groups
- Action FCS
- Professional groups
- Royal College of Physicians
- Assessment group
- York Technology Assessment Group,
- Associated public health groups
- None
- Comparator companies
- Sobi (olezarsen) (Confidentiality agreement signed, participating)
- Akcea Therapeutics (volanesorsen) (Confidentiality agreement not signed, not participating)
- General commentators
- All Wales Therapeutics and Toxicology Centre
- British National Formulary
- Department of Health - Northern Ireland
- Healthcare Improvement Scotland
- Medicines and Healthcare products Regulatory Agency
- Scottish Medicines Consortium
- Welsh Government
- Relevant research groups
- None
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 10 December 2025 | Invitation to participate |
| 23 July 2025 - 20 August 2025 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
| 23 July 2025 | In progress. Scoping commenced. |
| 10 June 2025 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on our processes and methods, please see our CHTE processes and methods manual